cancer screening Mainz Biomed, Dante Labs Partner to Commercialize ColoAlert in Europe, UAE Dante labs will market the test in Italy and the UAE, with Mainz initially processing samples in its lab and Dante later adopting IVD kits for in-house use. VolitionRx Bets on Canine Cancer Screening Test as Nucleosome Tech Development Continues Premium The company recently signed on Heska for selling its Nu.Q Vet Cancer Screening Test at the point of care, and Sage Healthcare as a distributor in Singapore. Delfi Diagnostics, Memorial Sloan Kettering Partner to Advance Cancer Screening Technology The partners' first project is an expansion of Delfi's previously announced prospective study of its blood-based screening assay in patients with a high risk of lung cancer. Intermountain Healthcare Rolling Out Galleri Multi-Cancer Early Detection Test in Pilot Program Premium The test is first available to employees over age 50 covered under Intermountain's SelectHealth, but the health system has a bigger five-year plan. Exai Bio Commercializing Noncoding RNA Method for Liquid Biopsy Applications Premium The company is assessing a variety of applications, including cancer early detection, using algorithms to analyze orphan noncoding RNA in blood. Apr 28, 2022 As Competing Blood-Based Cancer Screening Tests Loom, Exact Sciences Stresses Cologuard Advantage Premium Apr 27, 2022 PetDx-led Team Clinically Validates Liquid Biopsy Test for Canine Cancers Apr 21, 2022 Consensus Builds for Real-World Evidence to Support Multi-Cancer Screening Tests Premium Apr 13, 2022 Guardant Health, Exact Sciences Make Progress on Multi-Cancer Detection Tests Premium Feb 25, 2022 As CRC Screening Launch Approaches, Guardant Health Plans New Comprehensive Assay Premium Feb 15, 2022 Point32Health to Offer Grail Cancer Early Detection Test Under Pilot Program Feb 14, 2022 Mainz Biomed Partners with German Regional Lab on Colorectal Cancer Test Commercialization Feb 8, 2022 C2i Genomics, Twist Bioscience Partner to Develop Whole-Genome Cancer Reference Materials Feb 2, 2022 President Biden Jumpstarts Cancer Moonshot Initiative With Goal of Halving Death Rate Jan 19, 2022 Mainz Biomed Taps DCN Dx to Aid European Study of Enhanced ColoAlert Assay Jan 11, 2022 Freenome Nets $290M Investment From Roche Jan 7, 2022 Banner Year for Blood-Based Cancer Screening in 2021, but Reimbursement and Utility Hurdles Loom Premium Dec 14, 2021 Massive Bio Launches Plan to Enroll 100K Cancer Patients Into Clinical Trials Premium Dec 10, 2021 GE Healthcare Precision Oncology Pacts Focus on Cracking Data Silos, Improving Patient Outcomes Premium Oct 28, 2021 Veracyte Builds Data for Lung Cancer Swab Test, Begins Limited Launch Premium Aug 11, 2021 Sema4, Avera Health Collaborate on Precision Oncology Program Aug 6, 2021 NeoGenomics Q2 Revenues Grow 40 Percent Aug 5, 2021 Berry Oncology Raises $99.2M in Series B1 Round Jul 22, 2021 Sema4 Closes SPAC Deal With CM Life Sciences, Raising Approximately $500M Premium Jul 20, 2021 C2i Genomics Teams With Premier for AI-Driven Minimal Residual Disease Detection Load More Breaking News Canadian Healthcare Providers, Policymakers Value Different Aspects of Clinical Genomic Sequencing New Products Posted to GenomeWeb: Oxford Nanopore, Bio-Rad, NanoString, More People in the News at OraSure, Element Biosciences, Micronoma, More Guardant Health Files Motions to Dismiss, Change Venue in Illumina Patent Lawsuit In Brief This Week: SQI Diagnostics, T2 Biosystems, Enhanc3D, QuidelOrtho, More Illumina, Precision Health Research Singapore Partner for 100K Genomes Population Study The Scan Blend of Omicron With Delta The Associated Press reports that currently circulating Omicron variants have some features previously seen in the Delta variant. Limited Contrast The New York Times reports that there is a shortage of a contrast agent used for some medical scans. Pig Improvement Farmers in China are using genetics to improve their hog herds, according to Reuters. Science Papers Present Way to Molecularly Classify Prostate Cancer, Saliva-Based SARS-CoV-2 Test, More In Science this week: approach to molecularly classify prostate tumors, saliva-based test for SARS-CoV-2, and more.